Yeah, we make decisions like that at work all the time too. The figures are useless without comparing the specs for the equipment and what they are needed for. We have multi-million dollar machines that can screen thousands of compounds a day for pharmacokinetic activity. We could have spent much less, but then we wouldn't be able to explore as many possible compounds in our POC studies.
Or anyone who wants can read about them here, instead of taking some internet poster at their word:
Performance Indicators - NRC-CNRC
Some highlights:
In 2007-08, the total new companies created since 1995 remains at 68, accounting for approximately 552 full-time jobs and an estimated $470 million in cumulative investment, an 8% increase from last year. In 2007, investment from all sources into NRC new companies was $87 million.
...
In 2007-08, NRC researchers participated in 118 research networks, held 217 positions on editorial boards of scientific journals and were appointed to 473 adjunct professorships in Canadian universities. In 2007-08, NRC researchers and their university partners received 207 grants from Canadian granting agencies (such as NSERC and Genome Canada). The total of these grants, over the lifetime of the projects, equalled $29.3 million.
207 grants for under $30 million. Hardly the $3 million figure you listed to study the effects of sunlight on water.
In addition to working with university partners, NRC signed 407 new collaborative research agreements with Canadian partners worth a total of $159 million in 2007-08. The total value over the lifetime of these agreements grew to $493 million. The number and value of collaborative agreements signed during a year are indicators that foretell increased research activity. NRC's Canadian partners invest $3.10 for every dollar NRC invests.
That's a pretty significant investment. Anyone who works with this stuff would know that the investments are matched and exceeded by partners in academia and industry. There are payoffs to industry. How do you conduct new applied science in a pharmaceutical, or engineering capacity without furthering basic fundamental science?
Yes, exactly. Let's not have politicians who know zilch about it making decisions that impact Canadian industry and productivity.